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Introduction {#sec005}
============

Tuberculosis (TB) is a global public health problem and remains a great burden throughout the world, although there has been an overall decline in TB incidence and mortality to this date. In 2013, an estimated 9 million people developed TB, and 1.5 million died from the disease, including 360,000 deaths in HIV-positive people. Many countries have high rates of TB and HIV co-infection \[[@pone.0140634.ref001]\]. A prospective study indicated a TB incidence rate of 6.9/100 persons per year in patients infected with HIV in India \[[@pone.0140634.ref002]\].

In recent years, there has been a significant improvement in our understanding that vitamin D can influence the pathophysiology and possible prevention of human disease. Vitamin D is now considered to be a key factor of the body's defence against TB through its action of enhancing macrophage-mediated eradication of *Mycobacterium tuberculosis* \[[@pone.0140634.ref003]\]. It has been shown that vitamin D deficiency and insufficiency are associated with a higher risk of active TB \[[@pone.0140634.ref004]\]. The vitamin D receptor (VDR) gene is located in the chromosomal 12q13 region, and there are four important gene polymorphisms (*Fok*I, *Bsm*I, *Apa*I, *Taq*I). The polymorphisms of *Fok*I of the VDR gene, which transition C to T (rs10735810, usually "F" represented C and "f" for T) at the first of the two potential translation initiation sites in exon 2, is related to plasma vitamin D levels in TB patients \[[@pone.0140634.ref005]\]. Therefore, the polymorphisms of *Fok*I have been studied in relation to TB in many populations \[[@pone.0140634.ref006]--[@pone.0140634.ref019]\].

However, previous literature about the associations between *Fok*I polymorphism and the risk of TB has provided inconsistent results \[[@pone.0140634.ref006]--[@pone.0140634.ref019]\]. A previous meta-analysis found that *Fok*I polymorphism was associated with TB risk with significant heterogeneity \[[@pone.0140634.ref020], [@pone.0140634.ref021]\]. However, they did not stratify by HIV status. Since TB is the frequent major opportunistic infection in HIV-infected patients, genetic susceptibility to TB in HIV patients might also change \[[@pone.0140634.ref022]\]. We hypothesise that HIV infection status is the source of heterogeneity in previous studies, and that it is necessary to exclude the studies with HIV-positive TB to avoid selection bias, and that the stratification of HIV status would further reveal the relationship between *Fok*I polymorphism and TB. Therefore, a meta-analysis was carried out to derive a more reliable assessment on VDR *Fok*I polymorphism and the risk of HIV-negative TB.

Methods {#sec006}
=======

This meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement([S1 PRISMA Checklist](#pone.0140634.s001){ref-type="supplementary-material"} and [S1 Table](#pone.0140634.s002){ref-type="supplementary-material"}), including the search strategy, selection criteria, data extraction, and data analysis \[[@pone.0140634.ref023]\].

Literature Search {#sec007}
-----------------

We used the Embase, PubMed, and Cochrane Library databases to undertake a comprehensive systematic literature review of all current published VDR gene *FOKI* association studies aimed at the risk of TB up to June 30, 2015. The search terms were used as follows: *vitamin D receptor* or *VDR* in combination with *polymorphism*, *polymorphisms*, and *mutation* or *variant* in combination with *tuberculosis* or *TB* or *phthisic* or *phthisis*. Two investigators (CX and PT) conducted an extensive literature search independently for all publications. Articles in reference lists were also hand-searched. Only English articles and human studies were searched.

Inclusion and Exclusion Criteria {#sec008}
--------------------------------

Studies aiming to evaluate the association between VDR gene *FOKI* polymorphism and the susceptibility to HIV negative-TB were selected. The inclusion criteria were as follows:

1.  Case-control or cohort design studies had to include data regarding the baseline characteristics of the patients (number, age, sex). In addition, the inclusion and exclusion criteria for recruiting TB patients had to be clearly indicated.

2.  All the patients in studies had to be HIV-negative.

3.  Studies had to offer the ability to extract data for calculating the odds ratio (OR), 95% confidence intervals (CIs), and Hardy-Weinberg equilibrium (HWE).

4.  DNA genotyping methods and the sources of cases and controls were stated in studies.

Review articles, case reports, editorials, conference abstracts, letters and family-based studies were excluded.

Data Extraction {#sec009}
---------------

Two reviewers (CX and PT) independently assessed publications for inclusion in the review. Data extracted from eligible studies included the baseline characteristics, such as the first author's name, publication year, country, ethnicity, total sample size, genotyping method, and source of control group. Details of TB types and genotype frequencies of cases and controls were obtained. HWE was calculated from genotype frequencies of controls. Investigators would try to contact the author to get the original data if the literature could not provide sufficient data. To determine the accuracy of the extracted information by the two investigators, they checked their data if there was a dispute at first. If the two investigators could not reach an agreement, discrepancies were then resolved through discussion by the review team.

Assessment of Study Quality {#sec010}
---------------------------

To assess the validity of each study, we applied the criteria predefined by Thakkinstian et al. \[[@pone.0140634.ref024]\], with some criteria modified ([Table 1](#pone.0140634.t001){ref-type="table"}). The following important criteria were assessed: the sources of cases and controls, the total sample size, the specimens of cases, and the Hardy-Weinberg Equilibrium (HWE) of controls. According to the validity criteria shown in [Table 1](#pone.0140634.t001){ref-type="table"}, a study scoring \>10 was considered a high-quality study, while a score of ≤10 was classified as a low-quality study; the lowest score was 0 and the highest score was 15 \[[@pone.0140634.ref025]\].

10.1371/journal.pone.0140634.t001

###### Scale for quality assessment.

![](pone.0140634.t001){#pone.0140634.t001g}

  Criteria                                             Score
  ---------------------------------------------------- -------
  Representativeness of cases                          
   Selected from population or tuberculosis registry   3
   Selected from hospital                              2
   Not described                                       1
  Representativeness of controls                       
   Population-based                                    3
   Blood donors or volunteers                          2
   Hospital-based(cancer-free patients)                1
   Not described                                       0
  Specimens of cases determining genotypes             
   White blood cells or normal tissues                 3
   Tumor tissues or exfoliated cells of tissue         0
  Hardy-Weinberg equilibrium in controls               
   Hardy-Weinberg equilibrium                          3
   Hardy-Weinberg disequilibrium                       0
  Total sample size                                    
   ≥1000                                               3
   ≥500 but \<1000                                     2
   ≥200 but \<500                                      1
   \<200                                               0

Statistical Analysis {#sec011}
--------------------

According to a previous meta-analysis \[[@pone.0140634.ref021]\], f is the risk allele; therefore, the comparison models to access the association between VDR gene *FOKI* polymorphism and the susceptibility to HIV-negative TB including an allelic model (f vs. F), co-dominant model (ff vs. FF, fF vs. FF and ff vs. fF), a dominant model (ff+fF vs. FF), and a recessive model (ff vs. fF+FF). Unadjusted odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were used to measure the strength of the models because it is difficult to get the all original data from authors.

To dictate the best genetic model and avoid the problem of multiple comparisons, we applied the method for meta-analysis of molecular association studies \[[@pone.0140634.ref026]\]. OR~1~, OR~2~, and OR~3~ were calculated for the genotypes ff vs. FF (OR~1~), fF vs. FF (OR~2~), and ff vs. fF (OR~3~). These pairwise differences can be used to indicate the best genetic model, as outlined below:

1.  If OR~1~ = OR~3~≠1 and OR~2~ = 1(OR~1~ and OR~3~ were equal and had significant effects while OR2 was not significant.), then a recessive model is suggested.

2.  If OR~1~ = OR~2~≠1 and OR~3~ = 1, then a dominant model is suggested.

3.  If OR~2~ = 1/OR~3~≠1 and OR~1~ = 1, then a complete overdominant model is suggested.

4.  If OR~1~ \>OR~2~\>1 and OR~1~ \>OR~3~\>1 (or OR~1~\<OR~2~\<1 and OR~1~ \<OR~3~\<1), then a dominant model is suggested.

Heterogeneity was assessed by a chi-squared Q test and I-squared (*I* ^*2*^) statistics and classified as low (*I* ^*2*^\<25%), moderate (*I* ^*2*^ = 25--50%), and high (*I* ^*2*^\>50%), with a cut-off P-value of 0.10. A random-effects model was conducted using the DerSimonian and Laird method to calculate the summary OR and the corresponding 95% CI; otherwise, a fixed-effects model (the Mantel---Haenszel method) was used \[[@pone.0140634.ref027], [@pone.0140634.ref028]\]. The HWE in the controls was tested by the chi-square test for goodness of fit, and a *P*-value \<0.05 was considered out of HWE. We also carried out a subgroup analysis by ethnicity, genotyping method, source of controls, TB type, HWE, and score by quality assessment, respectively.

To verify the robustness of the findings, sensitivity analysis was conducted to examine such influences by removing studies one by one, especially removing the study out of HWE, and recalculating the pooled OR and 95% CI. If the corresponding pooled ORs were not qualitatively altered, we considered the results robust. The potential for publication bias was assessed with Begg's funnel plot and Egger's test \[[@pone.0140634.ref029], [@pone.0140634.ref030]\].

All the tests in this meta-analysis were conducted with the STATA software (version 12.0; Stata Corporation, College Station, Texas, USA) and RevMan 5.3 (Cochrane Collaboration). A P-value \<0.05 was considered statistically significant.

Results {#sec012}
=======

Study Inclusion and Characteristics {#sec013}
-----------------------------------

The search strategy identified 165 citations. Thirty-nine articles that were thought to be potentially eligible for inclusion were retrieved and evaluated after the titles and abstracts were reviewed, and 25 articles were excluded after full texts were reviewed according to the inclusion and exclusion criteria ([Fig 1](#pone.0140634.g001){ref-type="fig"}, [S2 Table](#pone.0140634.s003){ref-type="supplementary-material"}). Finally, a total of 14 studies, amounting to 1,668 patients and 1,893 control subjects, were retrieved in the meta-analysis \[[@pone.0140634.ref006]--[@pone.0140634.ref019]\].

![Flow diagram of included studies for this meta-analysis.](pone.0140634.g001){#pone.0140634.g001}

[Table 2](#pone.0140634.t002){ref-type="table"} lists the characteristics of eligible and included studies, including source of control, genotyping method, frequencies of genotype in case and control groups, HWE, and quality score. Of the remaining 14 articles we identified, 11 case-control studies were conducted in the Asian region \[[@pone.0140634.ref006], [@pone.0140634.ref008], [@pone.0140634.ref009], [@pone.0140634.ref012]--[@pone.0140634.ref019]\], 2 were African \[[@pone.0140634.ref007], [@pone.0140634.ref010]\], and only one was South American \[[@pone.0140634.ref011]\]. In addition, 11 studies focused on pulmonary TB (PTB), one on spinal TB, one on PTB and meningeal tuberculosis (MTB) and one did not show the type of TB ([Table 2](#pone.0140634.t002){ref-type="table"}). Only one study was out of HWE; it was also considered a low-quality study \[[@pone.0140634.ref014]\].

10.1371/journal.pone.0140634.t002

###### Characteristics of studies included in the meta-analysis.

![](pone.0140634.t002){#pone.0140634.t002g}

  Study       Year   Country        Total sample   TB    Source of Control   Genotyping method   Cases sequence   Control sequence   *P* ~HWE~   Quality scores                            
  ----------- ------ -------------- -------------- ----- ------------------- ------------------- ---------------- ------------------ ----------- ---------------- ----- ----- ---- ------- ----
  Alagarasu   2009   India          105            144   PTB                 PB                  SSP-PCR          65                 31          9                81    59    4    0.076   13
  Bobb        2007   South Africa   352            249   PTB                 PB                  RFLP-PCR         203                129         20               132   104   13   0.192   13
  Banoei      2010   Iranian        60             62    PTB                 PB                  SSP-PCR          30                 21          9                29    27    6    0.937   11
  Liu         2004   China          120            240   PTB                 PB                  RFLP-PCR         29                 63          28               85    120   35   0.482   12
  Lombard     2006   South Africa   104            117   PTB,MTB             HB                  SSP-PCR          68                 33          3                90    24    3    0.373   11
  Roth        2004   Peru           100            100   PTB                 HB                  RFLP-PCR         9                  32          59               7     36    57   0.689   11
  SALIMI      2015   Iran           120            131   PTB                 HB                  RFLP-PCR         65                 44          11               93    31    7    0.054   12
  Selvaraj    2008   India          51             60    PTB                 PB                  RFLP-PCR         31                 16          4                27    33    0    0.003   8
  Selvaraj    2009   India          65             60    PTB                 PB                  RFLP-PCR         33                 29          3                33    26    1    0.102   11
  Sinaga      2014   Indonesia      76             76    PTB                 HB                  RFLP-PCR         27                 42          7                30    34    12   0.650   11
  Singh       2011   East india     101            225   PTB                 HB                  RFLP-PCR         55                 40          6                96    110   19   0.107   11
  Wilkinson   2000   UK             91             116   TB                  HB                  RFLP-PCR         52                 31          8                74    39    3    0.418   11
  Wu          2013   China          213            211   PTB                 HB                  RFLP-PCR         72                 96          45               101   88    22   0.664   11
  Zhang       2010   China          110            102   spinal-TB           HB                  RFLP-PCR         16                 43          51               26    47    29   0.433   11

PB, Population---based; HB, Hospital---based; PTB, pulmonary tuberculosis; MTB, meningeal tuberculosis; SSP-PCR, sequence specific primer-polymerase chain reaction; RFLP-PCR, polymerase chain reaction-restriction fragment length polymorphism; HWE, Hardy---Weinberg equilibrium in control population

Quantitative Data Synthesis {#sec014}
---------------------------

The estimated OR1, OR2, and OR3 were 1.69 (95% CI = 1.19--2.41), 1.06 (95% CI = 0.83--1.35), and 1.48 (95% CI = 1.13--1.95), respectively ([Table 3](#pone.0140634.t003){ref-type="table"}). These indicated that OR~1~ = OR~3~≠1 and OR~2~ = 1, and suggested the genetic model was most likely to be recessive. Therefore, the FF and fF genotypes were combined and compared with ff (ff vs. FF+fF). The pooled OR was 1.60 (95% = 1.28--1.97, P\<0.001; *I* ^*2*^ = 29.5%, and *P* = 0.141 for heterogeneity). Summary results of comparisons are listed in [Table 3](#pone.0140634.t003){ref-type="table"}.

10.1371/journal.pone.0140634.t003

###### Meta-analysis of *FOKI* Polymorphism and HIV-negative TB risk.
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  Comparison         Group     No. of studies   Test of association   Heterogeneity                     
  ------------------ --------- ---------------- --------------------- --------------- --------- ------- -------
  **ff vs. FF**      overall   14               1.69                  1.19--2.41      0.004     39.5    0.064
  **fF vs. FF**      overall   14               1.06                  0.83--1.35      0.623     57.8    0.004
  **ff vs. fF**      overall   14               1.48                  1.13--1.95      0.005     19.6    0.240
  **ff vs. FF+fF**                                                                                      
  overall            14        1.60             1.28--1.97            \<0.001         29.5      0.141   
                     Asian     11               1.82                  1.42--2.33      \<0.001   31.0    0.150
                     Africa    2                1.10                  0.57--2.12      0.778     0.0     0.974
  SSP-PCR            3         1.96             0.97--4.00            0.061           0.0       0.537   
  RFLP-PCR           11        1.56             1.25--1.96            \<0.001         40.6      0.078   
  PTB                11        1.48             1.16--1.89            0.001           34.4      0.123   
  HWE                13        1.56             1.27--1.92            \<0.001         28.1      0.161   
  Score \> 10        13        1.56             1.27--1.92            \<0.001         28.1      0.161   
                     PB        6                1.75                  1.22--2.56      0.003     0.0     0.486
                     HB        8                1.52                  1.16--1.89      0.002     49.1    0.056

PB, Population---based; HB, Hospital---based; PTB, pulmonary tuberculosis; MTB, meningeal tuberculosis; SSP-PCR, sequence specific primer-polymerase chain reaction; RFLP-PCR, polymerase chain reaction-restriction fragment length polymorphism; HWE, Hardy---Weinberg equilibrium in control population

In the subgroup analysis by ethnicities, as shown in [Fig 2](#pone.0140634.g002){ref-type="fig"} and [Table 3](#pone.0140634.t003){ref-type="table"}, a significantly increased risk was found in the Asian group (OR = 1.82, 95% CI = 1.42--2.33, P\<0.001; *I* ^*2*^ = 31.0%, and *P* = 0.150 for heterogeneity) in the recessive model. However, no significant associations were found in the African group (OR = 1.10, 95% CI = 0.51--2.13, P = 0.778; *I* ^*2*^ = 0.0%, and *P* = 0.974 for heterogeneity). Because only one study was conducted in the South American population, the heterogeneity and pooled ORs could not be calculated. Significant associations were also found in the polymerase chain reaction-restriction fragment length polymorphism (RFLP-PCR) group, high-quality studies, and the population based (PB) and hospital based (HB) groups ([Table 3](#pone.0140634.t003){ref-type="table"}).

![Forest plot of VDR *Fok*I Polymorphism and HIV-negative TB risk in recessive model.](pone.0140634.g002){#pone.0140634.g002}

Sensitivity Analysis {#sec015}
--------------------

[Fig 3](#pone.0140634.g003){ref-type="fig"} shows the sensitivity analysis for VDR *Fok*I polymorphism and HIV-negative TB risk in recessive model. We first excluded the study of Selvaraj et al. \[[@pone.0140634.ref014]\], which was out of HWE, and the corresponding pooled ORs were not qualitatively altered (OR = 1.58, 95% CI = 1.27--1.92, P\<0.001). Statistically similar results were obtained after sequentially excluding each study.

![Sensitivity analysis for VDR *Fok*I Polymorphism and HIV-negative TB risk in recessive model.\
This figure shows the influence of individual studies on the summary OR. The middle vertical axis indicates the overall OR and the two vertical axes indicate its 95% CI. Every hollow round indicates the pooled OR when the left study is omitted in this meta-analysis. The two ends of every broken line represent the 95% CI.](pone.0140634.g003){#pone.0140634.g003}

Publication Bias {#sec016}
----------------

[Fig 4](#pone.0140634.g004){ref-type="fig"} shows the Begg's funnel plot in the recessive model. No significant publication bias was detected in the overall population. The statistical results of the Egger's test also provided evidence of funnel plot symmetry (*P* ~Egger's\ test~ = 0.682, 95% CI = --2.078--1.406).

![Begg's funnel plot for contrast in overall analysis in recessive model.\
Each point represents a separate study for the indicated association. Size graph symbol by weights. *Log\[OR\]* natural logarithm of OR. Horizontal line mean effect size.](pone.0140634.g004){#pone.0140634.g004}

Discussion {#sec017}
==========

The identification of host genetic factors, such as human leucocyte antigens (HLA), cytokines, and receptors, have been studied extensively to determine susceptibility to TB \[[@pone.0140634.ref010], [@pone.0140634.ref031], [@pone.0140634.ref032]\]. However, the results of these studies are different even for the same gene polymorphisms across populations. These inconsistent results might be due to various factors, such as various racial factors, different genotyping methods, and the characteristics of the patients included, such as age and sex. In addition, studies from India and other parts of the world have shown that genetic susceptibility to TB is influenced by HIV infection \[[@pone.0140634.ref033], [@pone.0140634.ref034]\]. However, many previous studies have not excluded HIV-positive TB patients from case groups \[[@pone.0140634.ref035]--[@pone.0140634.ref037]\], which would bring significant selection bias in case-control studies. Therefore, we carried out a meta-analysis focusing on the association between VDR *Fok*I polymorphism and the risk of HIV-negative TB. Our results suggests that individuals with an ff genotype increased about 1.60-fold risk of TB compared with F carries (FF or fF genotype) in the HIV-negative population, and 1.82-fold in the Asian group. Moderate heterogeneity was found in this study.

VDR *Fok*I polymorphism increasing the risk of TB is biologically plausible. Vitamin D is an important immunoregulatory hormone; 1,25(OH)2D3, the active form of vitamin D, modulates the production of monocytes, lymphocytes, and several interleukins and other cytokines, as well as various oncogenes and transcription factors via VDR. Upon binding to 1,25(OH)2D3, the VDR complex moves into the nucleus, where it regulates the expression of genes \[[@pone.0140634.ref038]\]. The activated VDR also plays a role in regulating the adaptive immune system by inhibiting lymphocyte proliferation and reducing the production of pro-inflammatory cytokines to prevent excessive responses \[[@pone.0140634.ref039]\]. A significant interaction between vitamin D status and VDR gene polymorphisms was also observed among Gujarati Asians in West London \[[@pone.0140634.ref040]\]. The significant association between low vitamin D levels and susceptibility to TB infection has also been found \[[@pone.0140634.ref041]\]. These studies suggested that VDR gene polymorphisms can influence the function of vitamin D and thus contribute to the susceptibility to TB infection.

As we know, gene polymorphisms are complicated and fluctuating, mainly due to various races and regions. Moreover, the burden of TB is highest in Asia and Africa geographically \[[@pone.0140634.ref001]\]. Therefore, although significant heterogeneity was not found in this meta-analysis, we still performed a subgroup analysis by ethnicity to best understand the race-specific effects on the association between VDR *Fok*I polymorphism and the risk of HIV-negative TB. As a result, a significant association was found in the Asian group when the ff genotype was compared with the FF and fF genotypes (OR = 1.82, 95% CI = 1.42--2.33), but not in the African and South American groups. However, there were only two studies focusing on African populations and one focusing on the South American population. In addition, we noticed that most of these studies from Asia were performed on Indian and Chinese populations. Considering that genetic background may be distinct among different populations, further studies on this topic in different ethnicities are expected to be conducted to strengthen our results.

Heterogeneity is the most common problem when explaining the results of a meta-analysis. Moderate heterogeneity was found in this study. However, heterogeneity was significantly reduced compared with previous meta-analyses \[[@pone.0140634.ref020], [@pone.0140634.ref021]\]. These results not only could confirm HIV infection status as the main source of heterogeneity in previous meta-analyses, but are also the reason why we conducted this study. Moderate heterogeneity in this meta-analysis was reasonable for various racial and different genotyping methods and the characteristics of the patients included, such as age and sex. We also carried out sensitivity analysis, and the corresponding pooled OR value did not differ significantly from that of the overall meta-analysis. Moreover, a Begg's funnel plot and an Egger's test showed no publication bias. These results indicate that our results are reliable.

The strengths of this study include focusing on HIV-negative TB patients to avoid selection bias, and the heterogeneity was significantly reduced compared with previous meta-analyses. We also used the best genetic model to avoid the problem of multiple comparisons. Therefore, although our results were similar to those of previous meta-analyses \[[@pone.0140634.ref021], [@pone.0140634.ref042]\], we think that our results are more credible than previous studies and are closed to the true relationship between *Fok*I polymorphism and TB. The main limitation of this study is that a more precise analysis could not be conducted of individual information, including other covariates such as age and sex, due to a lack in the original data of the reviewed studies. In addition, most of the case---control studies were conducted in Asians; thus, our results may be applicable only to this ethnic group. Finally, this study could not address gene---gene and gene---environment interactions.

Conclusion {#sec018}
==========

In summary, our meta-analysis suggested that VDR *Fok*I polymorphism contributes to increasing the risk of TB in HIV-negative individuals, especially in the Asian region. Further studies on this topic in other races are expected to be conducted in future.
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